0001127602-15-003048.txt : 20150128
0001127602-15-003048.hdr.sgml : 20150128
20150128151046
ACCESSION NUMBER: 0001127602-15-003048
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20150126
FILED AS OF DATE: 20150128
DATE AS OF CHANGE: 20150128
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: BIOCRYST PHARMACEUTICALS INC
CENTRAL INDEX KEY: 0000882796
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 621413174
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 2190 PARKWAY LAKE DR
CITY: BIRMINGHAM
STATE: AL
ZIP: 35244
BUSINESS PHONE: 2054444600
MAIL ADDRESS:
STREET 1: 2190 PARKWAY LAKE DR
CITY: BIRMINGHAM
STATE: AL
ZIP: 35244
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Powell Lynne
CENTRAL INDEX KEY: 0001631667
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-23186
FILM NUMBER: 15554613
MAIL ADDRESS:
STREET 1: 4505 EMPEROR BLVD.
STREET 2: SUITE 200
CITY: DURHAM
STATE: NC
ZIP: 27703
4
1
form4.xml
PRIMARY DOCUMENT
X0306
4
2015-01-26
0000882796
BIOCRYST PHARMACEUTICALS INC
BCRX
0001631667
Powell Lynne
4505 EMPEROR BLVD.
SUITE 200
DURHAM
NC
27703
1
Senior VP - CCO
Common Stock
2015-01-26
4
A
0
10000
0
A
10000
D
Emp. Stock Option (Right to Buy)
11.33
2015-01-26
4
A
0
190000
0
A
2015-01-26
2025-01-26
Common Stock
190000
190000
D
Initial award of Restricted Stock Units which will vest 100% on the first anniversary of the date of grant.
Initial Employee Option Grant becomes exercisable at the rate of 25% on each of the first, second, third and fourth anniversaries of the date of grant.
/s/ Lynne Powell
2015-01-28